Lee McDermott

1.3k total citations
22 papers, 996 citations indexed

About

Lee McDermott is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Lee McDermott has authored 22 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Rheumatology. Recurrent topics in Lee McDermott's work include Cancer, Hypoxia, and Metabolism (7 papers), Biochemical and Molecular Research (4 papers) and Fibroblast Growth Factor Research (3 papers). Lee McDermott is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Biochemical and Molecular Research (4 papers) and Fibroblast Growth Factor Research (3 papers). Lee McDermott collaborates with scholars based in United States, Italy and India. Lee McDermott's co-authors include Neil A. Hukriede, M. Hong Nguyen, M Wagener, Lizzie J. Harrell, Arthur J. Morris, David R. Snydman, Victor L. Yu, Takuto Chiba, Tatiana Novitskaya and Mark P. de Caestecker and has published in prestigious journals such as Journal of Biological Chemistry, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Lee McDermott

21 papers receiving 986 citations

Peers

Lee McDermott

NEPHR

PHEOH

Xiaohong Xiang China

Martin Leníček Czechia

S T Kunitake United States

Tomonori Hada Japan

Shuqi Mao China

Suyu Wang China

Yong Lin China

Margarita de la Llera Moya United States

Wenjing Zai China

Xiaohong Xiang China

Lee McDermott

763 ×1.2

471 ×2.2

38 ×0.3

117 ×0.8

NEPHR

28 ×0.3

PHEOH

Citations per year, relative to Lee McDermott Lee McDermott (= 1×) peers Xiaohong Xiang

Countries citing papers authored by Lee McDermott

Since Specialization

Citations

This map shows the geographic impact of Lee McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee McDermott more than expected).

Fields of papers citing papers by Lee McDermott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee McDermott. The network helps show where Lee McDermott may publish in the future.

Co-authorship network of co-authors of Lee McDermott

This figure shows the co-authorship network connecting the top 25 collaborators of Lee McDermott. A scholar is included among the top collaborators of Lee McDermott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee McDermott. Lee McDermott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McDermott, Lee, et al.. (2025). Extracting Informative Glycan-Specific Ions From Glycopeptide MS/MS Spectra With GlyCounter. Molecular & Cellular Proteomics. 24(12). 101085–101085. 1 indexed citations

Milano, Shawn K., Qingqiu Huang, Sekar Ramachandran, et al.. (2021). New insights into the molecular mechanisms of glutaminase C inhibitors in cancer cells using serial room temperature crystallography. Journal of Biological Chemistry. 298(2). 101535–101535. 24 indexed citations

McDermott, Lee, David Ryan Koes, Shabber Mohammed, et al.. (2019). GAC inhibitors with a 4-hydroxypiperidine spacer: Requirements for potency. Bioorganic & Medicinal Chemistry Letters. 29(19). 126632–126632. 8 indexed citations

Poloyac, Samuel M., Richard Bertz, Lee McDermott, & Punit Marathe. (2019). Pharmacological Optimization for Successful Traumatic Brain Injury Drug Development. Journal of Neurotrauma. 37(22). 2435–2444. 12 indexed citations

Tramonti, Angela, Alessandro Paiardini, Alessio Paone, et al.. (2018). Differential inhibitory effect of a pyrazolopyran compound on human serine hydroxymethyltransferase-amino acid complexes. Archives of Biochemistry and Biophysics. 653. 71–79. 14 indexed citations

Huang, Qingqiu, Clint A. Stalnecker, Chengliang Zhang, et al.. (2018). Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism. Journal of Biological Chemistry. 293(10). 3535–3545. 68 indexed citations

Gau, David, et al.. (2017). Structure-based virtual screening identifies a small-molecule inhibitor of the profilin 1–actin interaction. Journal of Biological Chemistry. 293(7). 2606–2616. 13 indexed citations

Pei, Fen, Hongchun Li, Mark J. Henderson, et al.. (2017). Connecting Neuronal Cell Protective Pathways and Drug Combinations in a Huntington’s Disease Model through the Application of Quantitative Systems Pharmacology. Scientific Reports. 7(1). 17803–17803. 16 indexed citations

McDermott, Lee, Lawrence A. Vernetti, Jingran Sun, et al.. (2016). Design and evaluation of novel glutaminase inhibitors. Bioorganic & Medicinal Chemistry. 24(8). 1819–1839. 47 indexed citations

10.

Paiardini, Alessandro, Alessio Fiascarelli, Serena Rinaldo, et al.. (2015). Screening and In Vitro Testing of Antifolate Inhibitors of Human Cytosolic Serine Hydroxymethyltransferase. ChemMedChem. 10(3). 490–497. 26 indexed citations

11.

McDermott, Lee. (2015). Allosteric MEK1/2 Inhibitors for the Treatment of Cancer: an Overview. 1(1). 6 indexed citations

12.

Marani, Marina, Alessio Paone, Alessio Fiascarelli, et al.. (2015). A pyrazolopyran derivative preferentially inhibits the activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells. Oncotarget. 7(4). 4570–4583. 45 indexed citations

13.

Qian, Wei, Jingnan Wang, Vera Roginskaya, et al.. (2014). Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells. Oncotarget. 5(12). 4180–4194. 88 indexed citations

14.

Cosentino, Chiara, Nataliya Skrypnyk, Takuto Chiba, et al.. (2013). Histone Deacetylase Inhibitor Enhances Recovery after AKI. Journal of the American Society of Nephrology. 24(6). 943–953. 153 indexed citations

15.

Sanker, Subramaniam, M. Cecilia Cirio, Laura L. Vollmer, et al.. (2013). Development of High-Content Assays for Kidney Progenitor Cell Expansion in Transgenic Zebrafish. SLAS DISCOVERY. 18(10). 1193–1202. 23 indexed citations

16.

Marek, Lindsay A., Kathryn E. Ware, Jennifer E. Smith, et al.. (2008). Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells. Molecular Pharmacology. 75(1). 196–207. 180 indexed citations

17.

McDermott, Lee, et al.. (2006). Biological Evaluation of a Multi‐Targeted Small Molecule Inhibitor of Tumor‐Induced Angiogenesis.. ChemInform. 37(28). 1 indexed citations

18.

McDermott, Lee, Mary Ellen Simcox, Brian Higgins, et al.. (2005). RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor: Synthesis and biological evaluation. Bioorganic & Medicinal Chemistry. 13(16). 4835–4841. 17 indexed citations

19.

Simcox, Mary Ellen, Brian Higgins, Lee McDermott, et al.. (2004). 189 Rodent pharmacokinetics and antiangiogenic activity of a pyrimidopyrimidine dual KDR/FGFR antagonist. European Journal of Cancer Supplements. 2(8). 59–59. 3 indexed citations

20.

Nguyen, M. Hong, Victor L. Yu, Arthur J. Morris, et al.. (2000). Antimicrobial Resistance and Clinical Outcome of Bacteroides Bacteremia: Findings of a Multicenter Prospective Observational Trial. Clinical Infectious Diseases. 30(6). 870–876. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact